KM Research Hub

LITERATURE

原始候选快照

v3 复核前的候选池,完整保留,仅供查看,不会自动重新处理。 共 7004 篇。

导出 CSV
论文标识日期入排置信度入排依据KM 状态
Efficacy and Safety of SmofKabiven® Versus Hospital-Compounded All-in-One Parenteral Nutrition in Chinese Patients Undergoing Gastrointestinal Surgery: A Multicenter, Randomized, Active-Controlled, Phase III Trial.Nutr CancerPMID 40598717无 PMCID20250.98未发现恶性肿瘤人群证据。待处理
Lebrikizumab Improved Itch Symptoms and Reduced Itch Interference on Sleep over 52 Weeks in Patients with Moderate-to-Severe Atopic Dermatitis in Two Phase 3 Trials.DermatologyPMID 40602386PMC1250026420250.98未发现恶性肿瘤人群证据。待处理
Peripheral blood cells as prognostic markers in patients with advanced non-small cell lung cancer treated with cemiplimab as monotherapy or in combination with chemotherapy.Cancer Treat Res Commun疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 当前未获得可用 PubMed/PMC Figure 图源,建议后续从出版商页补图源。PMID 40700835无 PMCID20250.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。无 KM 图
Long-term results of a randomized controlled trial of biosimilar CT-P16 and reference bevacizumab in patients with metastatic or recurrent non-small cell lung cancer.Cancer Treat Res Commun疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 当前未获得可用 PubMed/PMC Figure 图源,建议后续从出版商页补图源。PMID 40795416PMC1236886720250.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。无 KM 图
Bowel Preparation for Colonoscopy: The Patient Point of View.Dig DisPMID 41021426PMC1266871520250.98未发现恶性肿瘤人群证据。待处理
Safety and efficacy of vilaprisan in Japanese women with fibroids: The Phase 3 ASTEROID 8 trial.Womens Health (Lond)PMID 41059527PMC1251170720250.96主要研究目的为安全性/毒性或卫生经济学,未见合格 time-to-event 疗效终点。待处理
Efficacy in Japanese adults with growth hormone deficiency receiving weekly somapacitan or daily growth hormone: results from phase 3 REAL 1 trial.Front Endocrinol (Lausanne)PMID 39991735PMC1184223220250.98未发现恶性肿瘤人群证据。待处理
Low Infection Rates With Long-Term Dupilumab Treatment in Patients Aged 6 Months to 5 Years: An Open-Label Extension Study.Pediatr DermatolPMID 39529307PMC1195080520250.98未发现恶性肿瘤人群证据。待处理
Efficacy and safety of risankizumab versus methotrexate in patients with moderate-to-severe plaque psoriasis: results from IMMbrace, a randomized, double-blind, phase 3 study with an open-label extension period in Brazil.An Bras DermatolPMID 39648106PMC1196281420250.98未发现恶性肿瘤人群证据。待处理
Effect of empagliflozin on plasma lipids and lipoproteins in type 2 diabetes and heart failure - Empire HF and SIMPLE.J Clin LipidolPMID 39843293无 PMCID20250.98未发现恶性肿瘤人群证据。待处理
Characteristics and outcomes of patients with and without statin-associated muscle symptoms treated with bempedoic acid in the CLEAR Outcomes trial.J Clin LipidolPMID 39939212无 PMCID20250.98未发现恶性肿瘤人群证据。待处理
Efficacy and Safety of Once-Daily Roflumilast Cream 0.05% in Pediatric Patients Aged 2-5 Years With Mild-to-Moderate Atopic Dermatitis (INTEGUMENT-PED): A Phase 3 Randomized Controlled Trial.Pediatr DermatolPMID 39980188PMC1195080320250.98未发现恶性肿瘤人群证据。待处理
Neoadjuvant leukocyte interleukin injection immunotherapy improves overall survival in low-risk locally advanced head and neck squamous cell carcinoma -the IT-MATTERS study.Pathol Oncol Res疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 已检查 4 张 PMC Figure,均未识别为 KM 图:FIGURE 1:CONSORT/入组流程图;FIGURE 2:非 KM 图;FIGURE 3:非 KM 图;FIGURE 4:非 KM 图。PMID 40191245PMC1196832420250.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。无 KM 图
Randomized Controlled Trial of the Behavioral Intervention for Increasing Physical Activity in Multiple Sclerosis Project: Fidelity Monitoring and Outcomes.Behav MedPMID 39287190无 PMCID20250.98未发现恶性肿瘤人群证据。待处理
Immunogenicity and safety of a multi-human dose formulation of Biological E's 14-valent pneumococcal polysaccharide conjugate vaccine (PNEUBEVAX 14®) administered to 6-8-week-old healthy infants: a phase 3, single-blind, randomized, active-controlled study.Front ImmunolPMID 40260247PMC1201014420250.98未发现恶性肿瘤人群证据。待处理
Reduced-volume radiotherapy versus conventional-volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open-label, noninferiority, multicenter, randomized phase 3 trial.CA Cancer J ClinPMID 39970442PMC1206162720250.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。已完成
Operational challenges and lessons learned from conducting febrile surveillance in a long-term randomized dengue vaccine trial in Latin America and Asia-Pacific.Travel Med Infect DisPMID 40120920无 PMCID20250.98未发现恶性肿瘤人群证据。待处理
12-Month Outcomes of a Prospective Randomized Trial Investigating Effects of IVIG on Top of rATG Versus rATG Alone in Pre-Sensitized Kidney Transplant Recipients: The INHIBIT Study.Transpl IntPMID 40458542PMC1212784720250.98未发现恶性肿瘤人群证据。待处理
Lanadelumab for prevention of attacks of non-histaminergic normal C1 inhibitor angioedema: results from the randomized, double-blind CASPIAN Study and CASPIAN open-label extension.Front ImmunolPMID 40469312PMC1213562420250.98未发现恶性肿瘤人群证据。待处理
Association of predicted lean body mass and fat mass with prognosis in patients with heart failure preserved ejection fraction.PLoS OnePMID 40446077PMC1212457920250.98未发现恶性肿瘤人群证据。待处理
Matching-adjusted indirect comparison of tislelizumab plus lenvatinib versus sintilimab plus bevacizumab biosimilar as first-line treatment for unresectable hepatocellular carcinoma.Front ImmunolAI 判定该论文不进入自动 KM 提取:The record reports a matching-adjusted indirect comparison (MAIC) analysis, not the results of a single human Phase III randomized controlled clinical trial. The underlying studies may be Phase III, but this publication synthesizes them indirectly.PMID 40625746PMC1223004220250.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。无 KM 图
Ceftobiprole versus ceftriaxone ± linezolid in Community-Acquired Bacterial Pneumonia (CABP): Re-analysis of a randomized, phase 3 study using 2020 FDA guidance.PLoS OnePMID 40554538PMC1218694820250.98未发现恶性肿瘤人群证据。待处理
The PD COMM Process Evaluation: Describing Interventions and Implementation in a UK Pragmatic Randomised Controlled Trial of Speech and Language Therapy for People With Parkinson's-Related Dysarthria.Int J Lang Commun DisordPMID 40637984PMC1224430220250.98未发现恶性肿瘤人群证据。待处理
A double-blind, placebo-controlled, randomized, multi-centre, phase III study of MLC901 (NeuroAiDTMII) for the treatment of cognitive impairment after mild traumatic brain injury.PLoS OnePMID 40638707PMC1224456320250.98未发现恶性肿瘤人群证据。待处理
Patient experience with familial chylomicronemia syndrome before and after olezarsen treatment: Qualitative interviews with clinical trial participants.J Clin LipidolPMID 40713231无 PMCID20250.98未发现恶性肿瘤人群证据。待处理
Generic Intravenous Amisulpride (QLG2069) for the Prevention of Postoperative Nausea and Vomiting in Adults: A Phase III, Multicenter, Randomized, Placebo-Controlled Study.Drug Des Devel TherPMID 40923005PMC1241444920250.98未发现恶性肿瘤人群证据。待处理
Melatonin agonist tasimelteon (HETLIOZ®) improves sleep in patients with primary insomnia: A multicenter, randomized, double-blind, placebo-controlled trial.PLoS OnePMID 40971945PMC1244900820250.98未发现恶性肿瘤人群证据。待处理
Prevalence of Molecular Markers of Resistance to Antimalarial Drugs Three Years After Perennial Malaria Chemoprevention in Sierra Leone.Gates Open ResPMID 41080970PMC1250842320250.98未发现恶性肿瘤人群证据。待处理
On-treatment modified Glasgow Prognostic Score (mGPS) in hepatocellular carcinoma treated with atezolizumab and bevacizumab provides prognostic information.Front Immunol入排复审未纳入:属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。PMID 41142780PMC1254637420250.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。无 KM 图
Prognostic value of patient-reported outcomes for survival in patients with advanced lung cancer receiving immune checkpoint inhibitors.Front ImmunolPMID 41194933PMC1258307720250.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。部分完成
Antibody response to tetanus, diphtheria, poliomyelitis, hepatitis B, and H. influenzae b vaccines in allogeneic hematopoietic stem cell transplant adult recipients: A multicenter trial.PLoS OnePMID 41144397PMC1255845120250.98未发现恶性肿瘤人群证据。待处理
Efficacy and safety of rimegepant for the acute treatment of migraine in Japan: A dose-ranging, double-blind, randomized controlled trial.HeadachePMID 40586377PMC1263852020250.98未发现恶性肿瘤人群证据。待处理
Association Between Cytomegalovirus Viremia Clearance and Post-Solid Organ Transplant Mortality in Patients With Refractory Cytomegalovirus Infection: SOLSTICE Post Hoc Analysis.Transpl Int入排复审未纳入:未发现恶性肿瘤人群证据。PMID 41384277PMC1268944320250.98未发现恶性肿瘤人群证据。无 KM 图
Dosimetry-guided peptide receptor radionuclide therapy in neuroendocrine tumors: interim safety analysis of the DUONEN trial.Front Endocrinol (Lausanne)已检查 7 张 PubMed Figure,均未识别为 KM 图:Figure 1:AI 判定为 other;Figure 2:AI 判定为 other;Figure 3:AI 判定为 other;Figure 4:AI 判定为 other;Figure 5:AI 判定为 other;另有 2 张未列出。PMID 41404513PMC1270274720250.96主要研究目的为安全性/毒性或卫生经济学,未见合格 time-to-event 疗效终点。无 KM 图
Impact of treatment interruption on the efficacy and safety of vunakizumab in patients with moderate-to-severe plaque psoriasis: a post-hoc analysis of a phase 3 trial.Front ImmunolPMID 41624863PMC1285509520250.98未发现恶性肿瘤人群证据。待处理
Safety and immunogenicity of conjugate vaccine for typhoid (Vi-DT): Finding from an observer-blind, active-controlled, randomized, non-inferiority, phase III clinical trial among healthy volunteers.Hum Vaccin ImmunotherPMID 38189360PMC107937082024-Dec-310.98未发现恶性肿瘤人群证据。待处理
A phase 3 randomized, open-label study evaluating the immunogenicity and safety of concomitant and staggered administration of a live, pentavalent rotavirus vaccine and an inactivated poliomyelitis vaccine in healthy infants in China.Hum Vaccin ImmunotherPMID 38509699PMC109626062024-Dec-310.98未发现恶性肿瘤人群证据。待处理
Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults.Hum Vaccin ImmunotherPMID 38512394PMC109626222024-Dec-310.98未发现恶性肿瘤人群证据。待处理
Lot-to-lot consistency, immunogenicity, and safety of the Ad26.ZEBOV, MVA-BN-Filo Ebola virus vaccine regimen: A phase 3, randomized, double-blind, placebo-controlled trial.Hum Vaccin ImmunotherPMID 38523332PMC109651062024-Dec-310.98未发现恶性肿瘤人群证据。待处理
Immunogenicity and safety of Ad26.RSV.preF/RSV preF protein vaccine at predicted intermediate- and end-of-shelf-life as an evaluation of potency throughout shelf life.Hum Vaccin ImmunotherPMID 38783590PMC111358722024-Dec-310.98未发现恶性肿瘤人群证据。待处理
Efficacy, reactogenicity, and safety of the adjuvanted recombinant zoster vaccine for the prevention of herpes zoster in Chinese adults ≥ 50 years: A randomized, placebo-controlled trial.Hum Vaccin ImmunotherPMID 38838170PMC112537072024-Dec-310.98未发现恶性肿瘤人群证据。待处理
Longitudinal cardiac magnetic resonance imaging following clinical response to rilonacept and prior to recurrence upon treatment suspension: a RHAPSODY subgroup analysis.Eur Heart J Cardiovasc ImagingPMID 39172552PMC116871142024-Dec-310.98未发现恶性肿瘤人群证据。待处理
A prospective, randomized, parallel, active controlled, phase III Indian study of immunogenicity and safety of two inactivated influenza vaccines - Vaxiflu-4 and Fluarix tetra in children aged 6 months to 35 months.Hum Vaccin ImmunotherPMID 39445787PMC115089452024-Dec-310.98未发现恶性肿瘤人群证据。待处理
Safety and immunogenicity of freeze-dried human rabies vaccines: A phase 3 clinical trial of Zagreb and Essen regimes.Hum Vaccin ImmunotherPMID 39535124PMC115629082024-Dec-310.98未发现恶性肿瘤人群证据。待处理
Accuracy of ESAT6-CFP10 skin test compared with tuberculin skin test in a healthy population: a randomized, blind, parallel controlled phase III clinical study.BMC Infect DisPMID 39736611PMC116842502024-Dec-300.98未发现恶性肿瘤人群证据。待处理
Attractive targeted sugar baits for malaria control in western Kenya (ATSB-Kenya): enrolment characteristics of cohort children and households.Malar JPMID 39736740PMC116870922024-Dec-300.98未发现恶性肿瘤人群证据。待处理
Investigating the association between labor pain and cessation of breastfeeding.Sci RepPMID 39732915PMC116824552024-Dec-280.98未发现恶性肿瘤人群证据。待处理
Sustained benefit of zanubrutinib vs ibrutinib in patients with R/R CLL/SLL: final comparative analysis of ALPINE.BloodPMID 39316666PMC117380312024-Dec-260.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。部分完成
Efficacy and safety of sarilumab in patients with rheumatoid arthritis stratified by age (<65 and ≥65 years): A post hoc analysis of Japanese Phase 3 clinical trials.Mod RheumatolPMID 39073574无 PMCID2024-Dec-250.98未发现恶性肿瘤人群证据。待处理
The effects of sarilumab as monotherapy and in combination with non-methotrexate disease-modifying anti-rheumatic drugs on unacceptable pain in patients with rheumatoid arthritis: A post-hoc analysis of the HARUKA phase 3 study.Mod RheumatolPMID 39073577无 PMCID2024-Dec-250.98未发现恶性肿瘤人群证据。待处理